LIWANLI Innovation Co Ltd (3054) - Total Assets

Latest as of June 2025: NT$776.15 Million TWD ≈ $24.45 Million USD

Based on the latest financial reports, LIWANLI Innovation Co Ltd (3054) holds total assets worth NT$776.15 Million TWD (≈ $24.45 Million USD) as of June 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

LIWANLI Innovation Co Ltd - Total Assets Trend (2003–2024)

This chart illustrates how LIWANLI Innovation Co Ltd's total assets have evolved over time, based on quarterly financial data. Also see LIWANLI Innovation Co Ltd stock valuation for the company's overall valuation and market capitalisation.

LIWANLI Innovation Co Ltd - Asset Composition Analysis

Current Asset Composition (December 2024)

LIWANLI Innovation Co Ltd's total assets of NT$776.15 Million consist of 47.8% current assets and 52.2% non-current assets. Review how much debt does LIWANLI Innovation Co Ltd carry to assess the company's total debt and financial obligations.

Asset Category	Amount (TWD)	% of Total Assets
Cash & Equivalents	NT$0.00	31.3%
Accounts Receivable	NT$8.84 Million	1.1%
Inventory	NT$27.36 Million	3.5%
Property, Plant & Equipment	NT$0.00	0.0%
Intangible Assets	NT$0.00	0.0%
Goodwill	NT$0.00	0.0%

Asset Composition Trend (2003–2024)

This chart illustrates how LIWANLI Innovation Co Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See today's stock price for LIWANLI Innovation Co Ltd for real-time trading data and today's change.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: LIWANLI Innovation Co Ltd's current assets represent 47.8% of total assets in 2024, an increase from 0.0% in 2003.
Cash Position: Cash and equivalents constituted 31.3% of total assets in 2024, up from 12.1% in 2003.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, a decrease from 3.0% in 2003.
Asset Diversification: The largest asset category is inventory at 3.5% of total assets.

LIWANLI Innovation Co Ltd Competitors by Total Assets

Key competitors of LIWANLI Innovation Co Ltd based on total assets are shown below.

Company	Country	Total Assets
Kamada TA:KMDA	Israel	ILA377.21 Million
Takeda Pharmaceutical Co Ltd ADR NYSE:TAK	USA	$15.42 Trillion
Viatris Inc NASDAQ:VTRS	USA	$35.04 Billion
Takeda Pharmaceutical Company Limited F:TKDA	Germany	€15.41 Trillion
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	China	CN¥14.18 Billion
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	China	CN¥10.21 Billion
Yipinhong Pharmaceutical Co Ltd Class A SHE:300723	China	CN¥4.49 Billion
Avadel Pharmaceuticals PLC NASDAQ:AVDL	USA	$199.45 Million

LIWANLI Innovation Co Ltd - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	13.30	12.75	9.10
Quick Ratio	11.28	11.30	8.35
Cash Ratio	0.00	0.00	0.00
Working Capital	NT$346.46 Million	NT$380.47 Million	NT$527.49 Million

LIWANLI Innovation Co Ltd - Advanced Valuation Insights

This section examines the relationship between LIWANLI Innovation Co Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.66
Latest Market Cap to Assets Ratio	0.18
Asset Growth Rate (YoY)	-5.0%
Total Assets	NT$792.19 Million
Market Capitalization	$145.09 Million USD

Valuation Analysis

Below Book Valuation: The market values LIWANLI Innovation Co Ltd's assets below their book value (0.18x), which may indicate investor concerns about asset quality or future growth.

Significant Asset Reduction: LIWANLI Innovation Co Ltd's assets decreased by 5.0% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.

Annual Total Assets for LIWANLI Innovation Co Ltd (2003–2024)

The table below shows the annual total assets of LIWANLI Innovation Co Ltd from 2003 to 2024.

Year	Total Assets	Change
2024-12-31	NT$792.19 Million ≈ $24.96 Million	-5.03%
2023-12-31	NT$834.17 Million ≈ $26.28 Million	+3.50%
2022-12-31	NT$805.93 Million ≈ $25.39 Million	-14.98%
2021-12-31	NT$947.90 Million ≈ $29.86 Million	-5.53%
2020-12-31	NT$1.00 Billion ≈ $31.61 Million	-11.52%
2019-12-31	NT$1.13 Billion ≈ $35.73 Million	+6.80%
2018-12-31	NT$1.06 Billion ≈ $33.45 Million	-33.87%
2017-12-31	NT$1.61 Billion ≈ $50.59 Million	-7.49%
2016-12-31	NT$1.74 Billion ≈ $54.68 Million	+4.62%
2015-12-31	NT$1.66 Billion ≈ $52.26 Million	-13.42%
2014-12-31	NT$1.92 Billion ≈ $60.37 Million	-10.56%
2013-12-31	NT$2.14 Billion ≈ $67.49 Million	+44.52%
2012-12-31	NT$1.48 Billion ≈ $46.70 Million	+19.98%
2011-12-31	NT$1.24 Billion ≈ $38.92 Million	+20.22%
2010-12-31	NT$1.03 Billion ≈ $32.38 Million	-16.72%
2009-12-31	NT$1.23 Billion ≈ $38.88 Million	+57.96%
2008-12-31	NT$781.16 Million ≈ $24.61 Million	+5.50%
2007-12-31	NT$740.41 Million ≈ $23.33 Million	-0.09%
2006-12-31	NT$741.11 Million ≈ $23.35 Million	+38.95%
2005-12-31	NT$533.37 Million ≈ $16.80 Million	-44.66%
2004-12-31	NT$963.72 Million ≈ $30.36 Million	-22.96%
2003-12-31	NT$1.25 Billion ≈ $39.41 Million	--

About LIWANLI Innovation Co Ltd

TW:3054 Taiwan Drug Manufacturers - Specialty & Generic

Market Cap

$145.09 Million

NT$4.61 Billion TWD

Market Cap Rank

#17882 Global

#923 in Taiwan

Share Price

NT$57.10

Change (1 day)

+2.70%

52-Week Range

NT$22.30 - NT$90.30

All Time High

NT$90.30